ACRV
Acrivon TherapeuticsANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
ACRV vs peer average
95/100
ACRV vs. peer average (A vs. D)
Grade spread
B 2 · C 2 · D 2 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
BYSI is the first available peer comparator.
Same-sector small-cap biotech comparator; mainly useful for event-driven volatility and financing sensitivity rather than direct pipeline overlap.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ACRV
Acrivon Therapeutics
BYSI
BeyondSpring
Grade
A
D
Momentum
88
43
Value
58
42
Sentiment
58
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs BYSI
ACRV / BYSI
Grade Position
Above peers
ACRV vs. peer average (A vs. D)
95/100
Momentum
88
ACRVValue
58
ACRVSentiment
58
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ACRV
BYSI is the first peer returned for this comparison set.